NCT03709992

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms: A Randomized Controlled Trial

• Status: Suspended
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Mansoura University · Academic / Other
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

This study will be conducted to compare the efficacy and safety of Trospium chloride versus Tamsulosin for treatment of ureteral stent related symptoms.

Detailed description

Eligible patients will be randomized to one of the two treatment groups. Group 1 patients will receive 30 mg of Trospium chloride tablet twice daily, while group 2 patients will receive 0.4 mg of Tamsulosin tablet once daily, until the stent is removed. Ureteral Stent Symptoms Questionnaire (USSQ) will be used to evaluate the symptoms of the patients with DJ stent after 2 weeks of inserting the stent.

Conditions

• Ureter Stone
• Quality of Life
• Ureter Obstruction

Interventions

Type	Name	Description
DRUG	Trospium Chloride	30 mg of Trospium chloride tablet twice daily
DRUG	Tamsulosin	0.4 mg of Tamsulosin tablet once daily

Timeline

• Start date: 2020-12-18
• Primary completion: 2024-08-01
• Completion: 2024-11-01
• First posted: 2018-10-17
• Last updated: 2023-10-12

Locations

1 site across 1 country: Egypt